2022 Q1 Form 10-Q Financial Statement

#000147793222000229 Filed on January 13, 2022

View on sec.gov

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1237	USD
CY2022Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	35074605	shares
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1768	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	49439	USD
CY2021Q3	us-gaap	Inventory Net InventoryNet	49439	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	50676	USD
CY2021Q3	us-gaap	Assets Current AssetsCurrent	51207	USD
CY2021Q4	us-gaap	Assets Assets	50676	USD
CY2021Q3	us-gaap	Assets Assets	51207	USD
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	120771	USD
CY2021Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	121239	USD
CY2021Q4	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	652289	USD
CY2021Q3	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	485603	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	100	USD
CY2021Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	100	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	773160	USD
CY2021Q3	us-gaap	Liabilities Current LiabilitiesCurrent	606942	USD
CY2021Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	0	USD
CY2021Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	0	USD
CY2021Q4	us-gaap	Liabilities Liabilities	773160	USD
CY2021Q3	us-gaap	Liabilities Liabilities	606942	USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	USD
CY2021Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	USD
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	35074605	shares
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	34874605	shares
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	35075	USD
CY2021Q3	us-gaap	Common Stock Value CommonStockValue	34875	USD
CY2021Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	320000	shares
CY2021Q3	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	520000	shares
CY2021Q4	us-gaap	Common Unit Issuance Value CommonUnitIssuanceValue	80000	USD
CY2021Q3	us-gaap	Common Unit Issuance Value CommonUnitIssuanceValue	180000	USD
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1033448	USD
CY2021Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	933648	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1871007	USD
CY2021Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1704258	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-722484	USD
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	-555735	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	50676	USD
CY2021Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	51207	USD
CY2021Q4	us-gaap	Professional Fees ProfessionalFees	108465	USD
CY2020Q4	us-gaap	Professional Fees ProfessionalFees	184563	USD
CY2021Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	42950	USD
CY2020Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	15488	USD
CY2021Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	15335	USD
CY2020Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	16667	USD
CY2021Q4	us-gaap	Operating Expenses OperatingExpenses	166750	USD
CY2020Q4	us-gaap	Operating Expenses OperatingExpenses	216718	USD
CY2021Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-166750	USD
CY2020Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-216718	USD
CY2021Q4	agtx	Interest Income InterestIncome	0	USD
CY2020Q4	agtx	Interest Income InterestIncome	-5	USD
CY2021Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-166750	USD
CY2020Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-216713	USD
CY2021Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2020Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2021Q4	us-gaap	Net Income Loss NetIncomeLoss	-166750	USD
CY2020Q4	us-gaap	Net Income Loss NetIncomeLoss	-216713	USD
CY2021Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.00
CY2020Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.01
CY2021Q4	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	34965716	shares
CY2020Q4	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	34489605	shares
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	-555735	USD
CY2021Q4	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	0	USD
CY2021Q4	us-gaap	Net Income Loss NetIncomeLoss	-166750	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-722484	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	223462	USD
CY2020Q4	us-gaap	Net Income Loss NetIncomeLoss	-216713	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	6749	USD
CY2021Q4	us-gaap	Net Income Loss NetIncomeLoss	-166750	USD
CY2020Q4	us-gaap	Net Income Loss NetIncomeLoss	-216713	USD
CY2021Q4	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	166219	USD
CY2020Q4	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-14949	USD
CY2021Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-531	USD
CY2020Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-231662	USD
CY2021Q4	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	USD
CY2020Q4	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	USD
CY2021Q4	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0	USD
CY2020Q4	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-531	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-231662	USD
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1768	USD
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	242750	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1237	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11088	USD
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2021Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	320000	shares
CY2021Q3	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	520000	shares
CY2021Q4	agtx	Shares Reserved For Future Issuance Amount SharesReservedForFutureIssuanceAmount	80000	USD
CY2021Q3	agtx	Shares Reserved For Future Issuance Amount SharesReservedForFutureIssuanceAmount	180000	USD
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	35074605	shares
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	34874605	shares
CY2021Q4	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	200000	shares
CY2021Q4	us-gaap	Share Price SharePrice	0.50

Files In Submission

Name	View Source	Status
0001477932-22-000229-index-headers.html	Edgar Link	pending
0001477932-22-000229-index.html	Edgar Link	pending
0001477932-22-000229.txt	Edgar Link	pending
0001477932-22-000229-xbrl.zip	Edgar Link	pending
agtx-20211130.xsd	Edgar Link	pending
agtx-20211130_cal.xml	Edgar Link	unprocessable
agtx-20211130_def.xml	Edgar Link	unprocessable
agtx-20211130_lab.xml	Edgar Link	unprocessable
agtx-20211130_pre.xml	Edgar Link	unprocessable
agtx_10q.htm	Edgar Link	pending
agtx_10q_htm.xml	Edgar Link	completed
agtx_ex311.htm	Edgar Link	pending
agtx_ex312.htm	Edgar Link	pending
agtx_ex321.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending